All regulatory closing conditions related to Novo Holdings’ $16.5 billion acquisition of U.S. contract drug maker Catalent have been fulfilled, the companies …
@2025 – All Right Reserved | Omni Wire
Tag:
OmniWire is an independent news agency dedicated to delivering unbiased, in-depth reporting on the stories that matter most. Our mission is to empower readers with accurate information and fresh perspectives on global and local events.
- 1241 E Main St, Stamford, CT 06902
- Phone: (866) 993-7467
- Email: [email protected]
- Support: [email protected]